Security key
50127T109
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)
CUSIP: 50127T109
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 82,360,607
- Total 13F value
- $1,606,956,703
- Share change
- +330,186
- Put/Call ratio
- 84%
- SEC-reported price per share
- $19.54
- Number of holders
- 178
- Value change
- +$4,044,498
- Number of buys
- 80
- Number of sells
- 70
- Shares outstanding
- 88,321,513
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
178
Top holders
10
KURA full security history
Ownership snapshot
Full 13F holder table
Kura Oncology, Inc. SEC filings
Kura Oncology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SUVRETTA CAPITAL MANAGEME...
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 8%
Showing 1-6 of 15 holder rows.
Quick read
SUVRETTA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SUVRETTA CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SUVRETTA CAPITAL MANAGEMENT, LLC
8%
BlackRock Finance, Inc.
7.9%
EcoR1 Capital, LLC
6.6%
DEERFIELD MANAGEMENT COMPANY, L.P.
6.1%
Paradigm Biocapital Advisors LP
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
8%
|
$145,563,620
7,069,627 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
7.9%
|
$143,425,947
6,965,806 shares
|
— | 30 Jun 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
6.6%
|
$119,563,474
5,806,871 shares
|
— | 30 Jun 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
6.1%
|
$111,424,247
5,411,571 shares
|
— | 30 Jun 2024 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
5.1%
|
$93,465,855
4,539,381 shares
|
— | 30 Jun 2024 |
| BVF INC/IL |
13F
Company
|
4.6%
|
$84,049,142
4,082,037 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
178
Shares
82,360,607
Rows available
178
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
173
Q3 2024 holders
178
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|